Clinical Trial Update: 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial assessing a multi-drug regimen including 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine in patients with anaplastic gli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Glioma
• Glioblastoma

Drugs mentioned

• 6-thioguanine (6-thioguanine)
• Capecitabine (capecitabine)
• CeeNU (lomustine)
• Celecoxib (Celecoxib)
• Temodar (Temozolomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anaplastic Glioma of Brain, Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2012-01-11